Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: May 3, 2022
Date Accepted: Jul 21, 2022
Date Submitted to PubMed: Oct 30, 2024

The final, peer-reviewed published version of this preprint can be found here:

Photosensitivity From Avapritinib: Pharamacovigilance Analysis

Venkatakrishnan A, Chu B, Aggarwal P

Photosensitivity From Avapritinib: Pharamacovigilance Analysis

JMIR Dermatol 2022;5(3):e39229

DOI: 10.2196/39229

PMID: 39475689

PMCID: 10334909

Photosensitivity from Avapritinib: A Pharamacovigilance Analysis

  • Ajit Venkatakrishnan; 
  • Brandon Chu; 
  • Pushkar Aggarwal

ABSTRACT

-


 Citation

Please cite as:

Venkatakrishnan A, Chu B, Aggarwal P

Photosensitivity From Avapritinib: Pharamacovigilance Analysis

JMIR Dermatol 2022;5(3):e39229

DOI: 10.2196/39229

PMID: 39475689

PMCID: 10334909

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.